Lumateperone long-acting injectable
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lumateperone long-acting injectable, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder [Phase 1]